Published in Int J Obes (Lond) on December 22, 2009
Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med (2012) 13.59
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia (2011) 3.97
Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes (2011) 2.23
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) (2013) 2.22
Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes (2013) 2.19
Gastric bypass and banding equally improve insulin sensitivity and β cell function. J Clin Invest (2012) 2.19
Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care (2013) 1.83
Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol (2011) 1.68
Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes (2013) 1.66
Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med (2010) 1.54
Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care (2010) 1.46
The effect of bariatric surgeries on nonalcoholic fatty liver disease. Saudi J Gastroenterol (2014) 1.39
Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients. Diabetes (2013) 1.37
Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33
A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. Am J Clin Nutr (2010) 1.32
Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care (2011) 1.21
Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc (2012) 1.11
Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients. Diabetes (2013) 1.09
The great debate: medicine or surgery: what is best for the patient with type 2 diabetes? Diabetes Care (2011) 1.06
Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring) (2011) 1.02
Bypassing the duodenum does not improve insulin resistance associated with diet-induced obesity in rodents. Obesity (Silver Spring) (2010) 1.02
Regulation of glucose homeostasis by GLP-1. Prog Mol Biol Transl Sci (2014) 0.97
Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy. Int J Obes (Lond) (2013) 0.94
Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery. ISRN Endocrinol (2012) 0.94
A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery. Diabetes Metab J (2014) 0.94
Bariatric surgery as a treatment option in patients with type 2 diabetes mellitus. World J Diabetes (2013) 0.94
Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery. J Physiol (2015) 0.91
Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass. Osteoporos Int (2013) 0.87
Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? Int J Obes (Lond) (2013) 0.86
Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol (2014) 0.85
Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes. Diabetes Obes Metab (2013) 0.84
Management of diabetes across the course of disease: minimizing obesity-associated complications. Diabetes Metab Syndr Obes (2011) 0.82
Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms. Diabetes Spectr (2012) 0.82
Weight Loss as a Cure for Type 2 Diabetes? Fact or Fantasy. Expert Rev Endocrinol Metab (2011) 0.81
Acylation stimulating protein reduction precedes insulin sensitization after BPD-DS bariatric surgery in severely obese women. Nutr Diabetes (2012) 0.80
Diabetes improvement following Roux-en-Y gastric bypass: understanding dynamic changes in insulin secretion and action. Diabetes (2014) 0.79
Tissue-specific effects of bariatric surgery including mitochondrial function. J Obes (2011) 0.79
Reduction of 8-iso-prostaglandin F2α in the first week after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) (2011) 0.79
A role for exercise after bariatric surgery? Diabetes Obes Metab (2015) 0.79
Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation. Obesity (Silver Spring) (2016) 0.78
Heterotopic pancreas in excluded stomach diagnosed after gastric bypass surgery. BMC Surg (2013) 0.77
Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress. Acta Physiol (Oxf) (2015) 0.77
Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery. Curr Diab Rep (2016) 0.77
Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles. Surg Obes Relat Dis (2011) 0.76
Bile acids and bariatric surgery. Mol Aspects Med (2017) 0.75
New lessons from gastric bypass: Impact of glucose-independent islet function. Obesity (Silver Spring) (2015) 0.75
The Gut Microbiota: The Gateway to Improved Metabolism. Gastroenterol Clin North Am (2016) 0.75
Metabolic improvements following Roux-en-Y surgery assessed by solid meal test in subjects with short duration type 2 diabetes. BMC Obes (2017) 0.75
Response to comment on Dutia et al. Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes 2014;63:1214-1223. Diabetes (2014) 0.75
A prospective evaluation of the influence of three bariatric procedures on insulin resistance improvement. Should the extent of undiluted bile transit be considered a key postoperative factor altering glucose metabolism? Wideochir Inne Tech Maloinwazyjne (2015) 0.75
Effects of different metabolic states and surgical models on glucose metabolism and secretion of ileal L-cell peptides: protocol for a cross-sectional study. BMJ Open (2016) 0.75
Changes in glycemia, insulin and gut hormone responses to a slowly ingested solid low-carbohydrate mixed meal after laparoscopic gastric bypass or band surgery. Int J Obes (Lond) (2017) 0.75
Glucose Metabolism After Gastric Banding and Gastric Bypass in Individuals With Type 2 Diabetes: Weight Loss Effect. Diabetes Care (2016) 0.75
Glucose regulation and cognitive function after bariatric surgery. J Clin Exp Neuropsychol (2015) 0.75
Gastric inhibitory polypeptide (GIP) is selectively decreased in the roux-limb of dietary obese mice after RYGB surgery. PLoS One (2015) 0.75
Physiology of weight loss surgery. Surg Clin North Am (2011) 0.75
Type 2 diabetes, bariatric surgery and the risk of subsequent gestational diabetes. Obstet Med (2011) 0.75
The effects of bariatric surgeries on nonalcoholic fatty liver disease. Surg Endosc (2016) 0.75
Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol (1979) 27.52
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA (2008) 13.69
Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg (1995) 9.02
Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg (2003) 6.50
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med (2004) 6.16
Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes (2002) 6.05
Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes (1992) 4.47
Pathogenesis of type 2 diabetes mellitus. Med Clin North Am (2004) 4.44
Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care (2007) 3.97
The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg (2006) 3.97
Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology (2003) 3.42
Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis (2007) 3.01
The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg (2004) 2.95
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia (2003) 2.80
Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab (2004) 2.71
Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab (2007) 2.68
Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab (2008) 2.60
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) (2009) 2.28
Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes (2007) 2.19
Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes (2006) 1.89
Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. Gastroenterology (2008) 1.78
Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring) (2006) 1.69
Mechanism for improved insulin sensitivity after gastric bypass surgery. J Clin Endocrinol Metab (2008) 1.62
Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg (2006) 1.49
Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes (2003) 1.49
A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg (2005) 1.32
First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care (2008) 1.28
Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women. J Gerontol (1993) 1.24
Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab (2008) 1.22
Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.18
Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy. Obes Surg (2008) 1.01
Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia (1997) 0.97
Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM. Diabetes (1994) 0.94
Critical assessment of the current guidelines for the management and treatment of morbidly obese patients. J Endocrinol Invest (2007) 0.92
The early effects of weight loss surgery on regional adiposity. Obes Surg (2005) 0.88
Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol (1993) 3.53
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia (2005) 2.67
An investigation of association between chronic musculoskeletal pain and cardiovascular disease in the Health Survey for England (2008). Eur J Pain (2013) 2.01
Insulin resistance in aging is related to abdominal obesity. Diabetes (1993) 1.86
Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia (2007) 1.82
Laparoscopic repair of giant paraesophageal hernia: 100 consecutive cases. Ann Surg (2000) 1.55
Low insertion of hepatic segmental duct VII-VIII is an important cause of major biliary injury or misdiagnosis. Am J Surg (1996) 1.53
Glucose kinetics during high-intensity exercise in endurance-trained and untrained humans. J Appl Physiol (1985) (1995) 1.48
A new correction factor for use in tracer estimations of plasma fatty acid oxidation. Am J Physiol (1995) 1.47
Plasma glucose kinetics during exercise in subjects with high and low lactate thresholds. J Appl Physiol (1985) (1992) 1.46
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma. Br J Cancer (2011) 1.44
TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol (1999) 1.41
Effects of repeated days of intensified training on muscle glycogen and swimming performance. Med Sci Sports Exerc (1988) 1.41
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia (2011) 1.38
Minimally invasive esophagectomy. Ann Thorac Surg (2000) 1.36
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes (1999) 1.31
A focus on surgical preoperative evaluation of the bariatric patient--the Cleveland Clinic protocol and review of the literature. Surgeon (2011) 1.30
Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus. Clin Pharmacol Ther (2007) 1.25
Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation (2001) 1.23
Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia (2003) 1.22
Insulin: new roles for an ancient hormone. Eur J Clin Invest (1999) 1.22
In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome. J Endocrinol (2006) 1.17
Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med (2012) 1.14
Case-control study on evaluation of BCG vaccination of newborn in Rangoon, Burma. Ann Trop Paediatr (1987) 1.13
Laparoscopic transhiatal esophagectomy for Barrett's esophagus with high grade dysplasia. JSLS (1999) 1.10
Muscle damage impairs insulin stimulation of IRS-1, PI 3-kinase, and Akt-kinase in human skeletal muscle. Am J Physiol Endocrinol Metab (2000) 1.08
A complication of Roux-en-Y gastric bypass: intestinal obstruction. Surg Endosc (2007) 1.07
Protein synthesis and breakdown in skin and muscle: a leg model of amino acid kinetics. Am J Physiol (1994) 1.07
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. Am J Physiol Endocrinol Metab (2000) 1.07
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. J Intern Med (2011) 1.07
Head and neck manifestations of neurofibromatosis. Laryngoscope (1986) 1.07
Outcomes after minimally invasive esophagomyotomy. Ann Thorac Surg (2001) 1.07
Pathway of free fatty acid oxidation in human subjects. Implications for tracer studies. J Clin Invest (1995) 1.06
Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes (1999) 1.04
Fasting hyperglycaemia blunts the reversal of impaired glucose tolerance after exercise training in obese older adults. Diabetes Obes Metab (2012) 1.01
A model for glucose control of insulin secretion during 24 h of free living. Diabetes (2001) 0.98
Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjects. J Clin Endocrinol Metab (2011) 0.97
Bariatric surgery for treatment of obesity. Int J Obes (Lond) (2011) 0.97
Repair of ventral hernias in morbidly obese patients undergoing laparoscopic gastric bypass should not be deferred. Surg Endosc (2003) 0.97
A single bout of concentric resistance exercise increases basal metabolic rate 48 hours after exercise in healthy 59-77-year-old men. J Gerontol A Biol Sci Med Sci (1997) 0.96
Involvement of PKC-iota in glioma proliferation. Cell Prolif (2008) 0.96
Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients. Diabetologia (2007) 0.95
Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer. Cell Death Dis (2013) 0.95
Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg (1997) 0.95
Outcomes of laparoscopic Toupet compared to laparoscopic Nissen fundoplication. Surg Endosc (2002) 0.95
Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. Int J Obes (Lond) (2012) 0.94
Substrate utilization in leg muscle of men after heat acclimation. J Appl Physiol (1985) (1987) 0.93
Improvements in exercise performance: effects of carbohydrate feedings and diet. J Appl Physiol (1985) (1987) 0.93
Influence of duration of obesity on the insulin resistance of obese non-diabetic patients. Int J Obes Relat Metab Disord (1998) 0.92
How safe is metabolic/diabetes surgery? Diabetes Obes Metab (2014) 0.92
Combined laparoscopic and thoracoscopic approach to esophagectomy. J Am Coll Surg (1999) 0.92
Fat metabolism during high-intensity exercise in endurance-trained and untrained men. Metabolism (2000) 0.91
Regulation of plasma fatty acid oxidation during low- and high-intensity exercise. Am J Physiol (1997) 0.91
Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg (1998) 0.91
Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab (1998) 0.90
Determinants of success during triathlon competition. Res Q Exerc Sport (1989) 0.90
The impact of laparoscopy on bariatric surgery. Surg Endosc (2005) 0.90
Relationship between glucose tolerance and glucose-stimulated insulin response in 65-year-olds. J Gerontol (1993) 0.89
Effect of reduced training on muscular strength and endurance in competitive swimmers. Med Sci Sports Exerc (1987) 0.89
Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes. Clin Pharmacol Ther (1997) 0.89
Alterations in hemodynamics and left ventricular contractility during carbon dioxide pneumoperitoneum. Surg Endosc (1996) 0.89
Levels of serum creatine kinase and myoglobin in women after two isometric exercise conditions. Eur J Appl Physiol Occup Physiol (1986) 0.88
Maternal factors that determine neonatal size and body fat. Curr Diab Rep (2001) 0.87
Tetanus neonatorum (a preliminary report of assessment of different therapeutic regimens). J Trop Pediatr (1981) 0.87
Minimally invasive surgical staging for esophageal cancer. Surg Endosc (2000) 0.87
Preliminary results of thoracoscopic Belsey Mark IV antireflux procedure. Surg Laparosc Endosc (1998) 0.87
Results of a randomized trial of HERMES-assisted versus non-HERMES-assisted laparoscopic antireflux surgery. Surg Endosc (2002) 0.86
Direct effect of GLP-1 infusion on endogenous glucose production in humans. Diabetologia (2012) 0.86
Sealing effect of fibrin glue on the healing of gastrointestinal anastomoses: implications for the endoscopic treatment of leaks. Surg Endosc (2004) 0.86
Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise. Diabetes (1995) 0.85
Xanthones from Garcinia mangostana (Guttiferae). Nat Prod Res (2006) 0.85
Euglycemic clamp study in clozapine-induced diabetic ketoacidosis. Ann Pharmacother (2001) 0.85
Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. Nutr Metab Cardiovasc Dis (2010) 0.84
Determination of the enrichment of the hydrogen bound to carbon 5 of glucose on 2H2O administration. Anal Biochem (2001) 0.84
Ghrelin suppression is associated with weight loss and insulin action following gastric bypass surgery at 12 months in obese adults with type 2 diabetes. Diabetes Obes Metab (2013) 0.84
Fat storage in athletes: metabolic and hormonal responses to swimming and running. Int J Sports Med (1990) 0.84
Insulin and exercise differentially regulate PI3-kinase and glycogen synthase in human skeletal muscle. J Appl Physiol (1985) (2000) 0.84
In vitro photoreactivation of ultraviolet-inactivated ribonucleic acid from tobacco mosaic virus. Photochem Photobiol (1974) 0.83
Mini-gastric bypass controversy. Obes Surg (2001) 0.83
Knowledge, attitudes and practice concerning tuberculosis in a growing industrialised area in Myanmar. Int J Tuberc Lung Dis (2012) 0.82
Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery. Diabetes Obes Metab (2014) 0.82
Metabolic adaptations of skeletal muscle to voluntary wheel running exercise in hypertensive heart failure rats. Physiol Res (2013) 0.81
Gastrointestinal surgery for obesity and diabetes: weight loss and control of hyperglycemia. Curr Atheroscler Rep (2012) 0.81
Influence of sodium bicarbonate on sprint performance: relationship to dosage. Med Sci Sports Exerc (1988) 0.81
Identification of a novel mutation (p.Ile198Thr) in gene TYR in a Pakistani family with nonsyndromic oculocutaneous albinism. Clin Exp Dermatol (2014) 0.81
Laparoscopic needle catheter jejunostomy. Br J Surg (2000) 0.81
New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery. Surg Endosc (2006) 0.80
Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis (2007) 0.80
Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity. Diabetologia (2013) 0.80
Subacute measles encephalitis with AIDS diagnosed by fine needle aspiration biopsy. A case report. Acta Cytol (1998) 0.80
Physiological and metabolic characteristics of elite tug of war athletes. Br J Sports Med (2001) 0.80
Effect of theophylline on substrate metabolism during exercise. Metabolism (1996) 0.80
Effects of pre-exercise carbohydrate feedings on muscle glycogen use during exercise in well-trained runners. Eur J Appl Physiol Occup Physiol (1987) 0.79
Determinants of postabsorptive endogenous glucose output in non-diabetic subjects. European Group for the Study of Insulin Resistance (EGIR). Diabetologia (2000) 0.79
Fluid replacement in sport and exercise--a consensus statement. Br J Sports Med (1993) 0.78
Effect of open and laparoscopic surgery on cellular immunity in a swine model. Surg Laparosc Endosc Percutan Tech (1999) 0.78